Anteralign Spinal System With Titan Nanolock Surface Technology
Payments companies reported to CMS as associated with Anteralign Spinal System With Titan Nanolock Surface Technology. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Anteralign Spinal System With Titan Nanolock Surface Technology, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Anteralign Spinal System With Titan Nanolock Surface Technology
These are the largest totals companies reported as associated with Anteralign Spinal System With Titan Nanolock Surface Technology. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Neelakantan Anand | Los Angeles, CA | Orthopaedic Surgery of The Spine | $141,503.35 |
| Jared Seale | Little Rock, AR | Orthopaedic Surgery of The Spine | $69,983.05 |
| David De Witt | Appleton, WI | Orthopaedic Surgery of The Spine | $59,394.00 |
| Adrian Thomas | Bedford, NH | Orthopaedic Surgery of The Spine | $48,635.60 |
| William Hotchkiss | Dallas, TX | Orthopaedic Surgery of The Spine | $30,091.64 |
| Stanley Hoang | Shreveport, LA | Neurological Surgery | $27,855.19 |
| Taylor Gist | Houston, TX | Neurological Surgery | $18,605.43 |
| Jed Vanichkachorn | Richmond, VA | Orthopaedic Surgery of The Spine | $18,498.27 |
| Heath Broussard | Jackson, TN | Surgery | $18,296.69 |
| Eiman Shafa | Minneapolis, MN | Orthopaedic Surgery of The Spine | $15,784.10 |
Prescribed Anteralign Spinal System With Titan Nanolock Surface Technology?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.